Tubercidin

For research use only.

Catalog No.S8095 Synonyms: 7-deaza-adenosine

1 publication

Tubercidin Chemical Structure

CAS No. 69-33-0

Tubercidin (7-deaza-adenosine), an adenosine analogue, is a nucleoside antibiotic. It is incorporated into DNA and inhibits polymerases, thereby inhibiting DNA replication and RNA and protein synthesis. This agent also exhibits antifungal and antiviral activities.

Selleck's Tubercidin has been cited by 1 publication

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Tubercidin (7-deaza-adenosine), an adenosine analogue, is a nucleoside antibiotic. It is incorporated into DNA and inhibits polymerases, thereby inhibiting DNA replication and RNA and protein synthesis. This agent also exhibits antifungal and antiviral activities.
In vitro

Continuous exposure for 14 days to tubercidin alone is highly toxic to both human CFU-GM and BFU-E. The IC50s of tubercidin are 3.4±1.7 and 3.7±0.2 nM for CFU-GM and BFU-E, respectively. Tubercidin also has a direct dose-dependent inhibitory effect on myeloid and erythroid human bone marrow progenitor cells in vitro[1].

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
L1210 NFPKUYtHfW6ldHnvckBie3OjeR?= NU\3V2JTS2:wY3XueJJifGmxbjDy[ZF2cXKnZDD0c{Bl\WO{ZXHz[UB1cGViZ4Lve5RpKHKjdHWgeI8hPTBnIH;mJINwdnS{b3yge4F{KGW4YXz1ZZRm\CCkeTDk[ZRmem2rbnnu[{B1cGWrcjDhZoltcXS7IITvJIlvcGmkaYSg[5Jwf3SqIH;mJGwyOjFyIHPlcIx{KGmwII\peJJwNCCLQ{WwQVAvODUQvF2= MYS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yOzFyN{S0K|4yOzFyN{S0QE9iRg>?
H.Ep.2 NWfwWHFMTnWwY4Tpc44h[XO|YYm= NEHx[4ZEd26lZX70doF1cW:wIILldZVqemWmIITvJIRm[3KnYYPlJJRp\SCpcn;3eIghemG2ZTD0c{A2OCVib3[gZ49vfHKxbDD3ZZMh\X[jbIXheIVlKGK7IHTleIVzdWmwaX7nJJRp\Wm{IHHibYxqfHlidH:gbY5pcWKrdDDndo94fGhib3[gTE5GeC5{IHPlcIx{KGmwII\peJJwNCCLQ{WwQVAvODcQvF2= NUDKPVZtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUOxNFc1PCd-MUOxNFc1PDxxYU6=
HFF cells NImx[4hEgXSxdH;4bYNqfHliYYPzZZk> NELGdoFEgXSxdH;4bYNqfHliYXfhbY5{fCC3bnnu[oVkfGWmIHj1cYFvKG[xcnXzb4lvKG[rYoLvZoxie3RqSF\GJINmdGy|KTygTWM2OD1yLkVOwG0> Mn;VQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NkizO{c,Ojh2NkizO|ww[T5?
KB cells NH3yV|BEgXSxdH;4bYNqfHliYYPzZZk> M1XLdmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJI5md3CuYYP0bYMh[2WubDDsbY5mMEuEIHPlcIx{MSxiSVO1NF0xNjcQvF2= NWrkc|NzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMki0Olg{Pyd-Mki0Olg{PzxxYU6=
L1210 MnXnR5l1d3SxeHnjbZR6KGG|c3H5 MnHnTY4hfmm2cn:gZ5l1d3SxeHnjbZR6KHejczDleoFtfWG2ZXSgZYdicW6|dDD0bIUhVDF{MUCgUZVzcW6nIHzleYtmdWmlIHPlcIx{NCCLQ{WwQVAvODUQvF2= Mlf0QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjlzM{OwNEc,OjlzM{OwNFww[T5?
HFF cells Mn3kR5l1d3SxeHnjbZR6KGG|c3H5 NH;YfotEgXSxdH;4bYNqfHlid3HzJIV3[Wy3YYTl[EBi\2GrboP0JJRp\SCKdX3hckBlcXCub3nkJINmdGy|IDjISmYqNCCLQ{WwQVAvO87:TR?= MUC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTF|M{CwK|4zQTF|M{CwQE9iRg>?
H.Ep.2 MnXESpVv[3Srb36gZZN{[Xl? NX3HSG9NS2:vcH;1coQhf2G|IHX2ZYx2[XSnZDDmc5Ih[3m2b4TvfIlkcXS7IHHnZYlve3RiSD7FdE4uOiClZXzsd{wh[W6mIHPvcoNmdnS{YYTpc44hemWzdXny[YQhfG9iaX7obYJqfCC2aHWg[5Jwf3SqIH;mJJRz\WG2ZXSgZ4VtdHNidH:gOVAmKG:oIIXueJJm[XSnZDDjc451em:uLjCsJGlEPTB;MD6wNFLPxE1? M{jKe|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzZ5MEiwOVQoRjZ5MEiwOVQ9N2F-
L1210 M1fHe2Z2dmO2aX;uJIF{e2G7 NYHR[Go4XGW|dHXkJIZweiCrbjD2bZRzdyClZXzsJIdzd3e2aDDpcohq[mm2aX;uJI9nKExzMkGwJINmdGy|LDDJR|UxRTBwMESz{txO NH[0fVE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi96MkW0OlE{Lz56MkW0OlE{RC:jPh?=
H.Ep.2 MmrrSpVv[3Srb36gZZN{[Xl? M1;NUnRme3SnZDDmc5IhcW5idnn0do8h[2WubDDndo94fGhiaX7obYJqfGmxbjDv[kBJNiCHcD6gNkBk\WyuczygTWM2OD1yLkC2{txO MUK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek85OjV2NkGzK|45OjV2NkGzQE9iRg>?
L2 MYTHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M{PoNlM4KHWP NG\BVVlIem:5dHigbY5pcWKrdHnvckBw\iCvb4Xz[UBNOiClZXzsd{BifCB|NzD1US=> Ml;NQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTd7N{e3NlgoRjF5OUe3O|I5RC:jPh?=
HeLaS3 MlfrRY51cX[rcnHsJIF{e2G7 NIXKUW4zKGSjeYO= MXXBcpRqfmm{YXygZYN1cX[rdImgZYdicW6|dDDQc4xqd3[rcoXzJIlv\mWldHXkJIlvKGi3bXHuJGhmVGGVMzDj[YxteyCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKH[rcnHsJJJmeGyrY3H0bY9vKHS{ZXH0[YQhOSCqcjDi[YZwemViaX7m[YN1cW:wIH3lZZN2emWmIHHmeIVzKDJiZHH5d{whUUN3ME2wMlA{|ryP M1HpSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOU[0OFA3Lz5{MEm2OFQxPjxxYU6=
HeLaS3 MmTqR5l1d3SxeHnjbZR6KGG|c3H5 NIq0eGQ1QCCqcoO= NYnqXnB7S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYWOzJINmdGy|IHHmeIVzKDR6IHjyd{BjgSClZXzseIl1\XJvZ3zvJIF{e2G7LDDJR|UxRTBwNN88US=> NFjLV4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEm2OFQxPid-MkC5OlQ1ODZ:L3G+
HeLaS3 MYPDfZRwfG:6aXPpeJkh[XO|YYm= NYWyUYZwOjRiaILz NXHvNVQ5S3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYWOzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSClZXzseIl1\XJvZ3zvJIF{e2G7LDDJR|UxRTBwOEG5{txO M176eFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyOU[0OFA3Lz5{MEm2OFQxPjxxYU6=
HeLaS3 MVzDfZRwfG:6aXPpeJkh[XO|YYm= NFnIPFg4KGi{cx?= M{nETWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGGVMzDj[YxteyCjZoTldkA4KGi{czDifUBk\WyudHn0[ZIu\2yxIHHzd4F6NCCLQ{WwQVEvPDUQvF2= MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODl4NESwOkc,OjB7NkS0NFY9N2F-
A549 Ml3jR5l1d3O2YYTpZ{Bie3OjeR?= NUP0XXlvPSCmYYnz M1nMb2N6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEWg[IF6eyCkeTDTVmIh[XO|YYmsJGdKPTB;MD6wNFHPxE1? M3\we|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{GxNFU1Lz5{MUexNVA2PDxxYU6=
HCT116 MYLDfZRwe3SjdHnjJIF{e2G7 MlPROUBl[Xm| NFrmOYZEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTGNVOTF4IHPlcIx{KGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUC9NE4xODIQvF2= NG[wUYM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUexNVA2PCd-MkG3NVExPTR:L3G+
NCI-H23 NHrJZmFEgXSxc4TheIlkKGG|c3H5 NWLyfGpmPSCmYYnz NF\l[m5EgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUmNKNUh{MzDj[YxteyCjZoTldkA2KGSjeYOgZpkhW1KEIHHzd4F6NCCJSUWwQVAvODFzzszN NVfDRnNqRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG3NVExPTRpPkKxO|EyODV2PD;hQi=>
HCT15 M4mxfmN6fG:|dHH0bYMh[XO|YYm= NHG3PXc2KGSjeYO= NU\Dc4xZS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhEXDF3IHPlcIx{KGGodHXyJFUh\GG7czDifUBUWkJiYYPzZZktKEeLNUC9NE4xOTIQvF2= M3TV[|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzN{GxNFU1Lz5{MUexNVA2PDxxYU6=
DU145 MVLDfZRwe3SjdHnjJIF{e2G7 MnX3OUBl[Xm| NGTrNHBEgXSxc4TheIlkKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gSHUyPDViY3XscJMh[W[2ZYKgOUBl[Xm|IHL5JHNTSiCjc4PhfUwhT0l3ME2wMlAyQM7:TR?= MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTdzMUC1OEc,OjF5MUGwOVQ9N2F-
MT4 MkW3R5l1d3O2YYTpZ{Bie3OjeR?= MoPlOUBl[Xm| MkD6R5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3UOEBk\WyuczDh[pRmeiB3IHThfZMh[nliU2LCJIF{e2G7LDDHTVUxRTBwMEKx{txO MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTdzMUC1OEc,OjF5MUGwOVQ9N2F-
PC3 M3;nWmN6fG:|dHH0bYMh[XO|YYm= MkLGOUBl[Xm| MkWzR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB3IHThfZMh[nliU2LCJIF{e2G7LDDHTVUxRTBwMES4{txO MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTdzMUC1OEc,OjF5MUGwOVQ9N2F-
Hs578 MVXDfZRwe3SjdHnjJIF{e2G7 NXm3V|I1PSCmYYnz M1P2[WN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDId|U4QCClZXzsd{Bi\nSncjC1JIRigXNiYomgV3JDKGG|c3H5MEBIUTVyPUCuNFk5|ryP MWW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTdzMUC1OEc,OjF5MUGwOVQ9N2F-
HEK293 MW\GeY5kfGmxbjDhd5NigQ>? NV2x[VQzW3SjYnnsbZpifGmxbjDv[kBR\GOmNDDlfJBz\XO|ZXSgbY4hcHWvYX6gTGVMOjl|IHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhXFCDLXnu[JVk\WRiZHXndoFl[XSrb36gZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCjc4PhfUwhUUN3ME2wMlg5|ryP MVG8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTh5MEiyPEc,OjF6N{C4Nlg9N2F-
MRC5 MXLBcpRqfHK7cHHuc5NwdWGuIHHzd4F6 M{LTNFch\GG7cx?= Mn7rRY51cXS{eYDhco9{d22jbDDhZ5Rqfmm2eTDh[4FqdnO2IH7p[pVzfGmvb4itd4Vve2m2aY\lJHRzgXCjbn;zc41iKGO{dYrpJHR2dGGqdXXuJGNNOiCqYYLic5JqdmdiYnX0ZU1o[WyjY4Tvd4ll[XOnIHnu[oVkfGWmIHnuJIh2dWGwIF3SR|Uh[2WubIOgZYZ1\XJiNzDkZZl{KGK7IILld4F7fXKrbjDkfYUu[mG|ZXSgZZN{[XluIFXDOVA:OC5|NN88US=> NXf4OHN7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxM{C2O|c3PjhpPkOwOlc4PjZ6PD;hQi=>
MRC5 NYjEfIFwS3m2b4TvfIlkcXS7IHHzd4F6 M37icFMh\GG7cx?= MmKzR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUXJEPSClZXzsd{Bie3Onc4Pl[EBieyC{ZXT1Z5Rqd25iaX6gZ4VtdCC4aXHibYxqfHliYX\0[ZIhOyCmYYnzJIJ6KHKnc3H6eZJqdiCmeXWtZoF{\WRiYYPzZZktKEWFNUC9Nk4zO87:TR?= NEDqSmQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|ME[3O|Y3QCd-M{C2O|c3Pjh:L3G+
Vero NFnIXZFHfW6ldHnvckBie3OjeR?= M1fZc2lvcGmkaYTpc44hd2ZiUl7BMYRmeGWwZHXueEBTVkFicH;sfY1memG|ZTDpckBbcWujII\pdpV{KE2UN{[2JIlv\mWldHXkJIlvKEGocnnjZY4h\3KnZX6gcY9vc2W7IG\ldo8h[2WubIOgZZN{\XO|ZXSgZZMh[W62aY\pdoFtKGGldHn2bZR6KGK7IH3leIh6dGWwZTDicJVmKHO2YXnubY5oKGKjc3XkJIJ6KFCuYYH1[UBz\WS3Y4Tpc44h[XO|YYmsJGVEPTB;MT6z{txO NH\CZ2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUW0PVg{Pid-M{G1OFk5OzZ:L3G+
Vero NVfldZFCTnWwY4Tpc44h[XO|YYm= MYjJcohq[mm2aX;uJI9nKFKQQT3k[ZBmdmSnboSgVm5CKHCxbInt[ZJie2ViaX6gXols[SC4aYL1d{BOWjd4NjDpcoZm[3SnZDDpckBC\nKrY3HuJIdz\WWwIH3vcotmgSCYZYLvJINmdGy|IHHzd4V{e2WmIHHzJIFvfGm4aYLhcEBi[3Srdnn0fUBjgSCDbHX4ZUBHdHWxcjC0PFgwTEGSSTDzeIFqdmmwZzDiZZNm\CCjc4PhfUwhTUN3ME2xMlPPxE1? M4H5UVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzNzNUS5PFM3Lz5|MUW0PVg{PjxxYU6=
Vero Ml30SpVv[3Srb36gZZN{[Xl? M33OW|Uh\GG7cx?= MWLJcohq[mm2aX;uJI9nKFKQQT3k[ZBmdmSnboSgVm5CKHCxbInt[ZJie2ViaX6gXols[SC4aYL1d{BOWjd4NjDpcoZm[3SnZDDpckBC\nKrY3HuJIdz\WWwIH3vcotmgSCYZYLvJINmdGy|IHHzd4V{e2WmIHHzJIFvfGm4aYLhcEBi[3Srdnn0fUBjgSCvZXHzeZJqdmdicnXkeYN1cW:wIHnuJJZqenW|LXnu[JVk\WRiY4n0c5BifGirYzDl[oZm[3RiYX\0[ZIhPSCmYYnzJIJ6KE2WUzDhd5NigSxiRVO1NF0yNjQQvF2= MoriQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOzF3NEm4N|YoRjNzNUS5PFM3RC:jPh?=
Vero NHLicnNHfW6ldHnvckBie3OjeR?= M3[1R2lvcGmkaYTpc44hd2ZiUl7BMYRmeGWwZHXueEBTVkFicH;sfY1memG|ZTDpckBbcWujII\pdpV{KE2UN{[2JIlv\mWldHXkJIlvKEGocnnjZY4h\3KnZX6gcY9vc2W7IG\ldo8h[2WubIOgZZN{\XO|ZXSgZZMh[W62aY\pdoFtKGGldHn2bZR6KGK7IH3lZZN2emmwZzDy[YR2[3Srb36gbY4hfmm{dYOtfYlmdGRuIFXDOVA:OS5|zszN NE\zeWk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9|MUW0PVg{Pid-M{G1OFk5OzZ:L3G+

... Click to View More Cell Line Experimental Data

In vivo Tubercidin at the dose regimen (5 mg/kg everyday for 4 days) is lethal when used alone. Some of the studies show that the mortality from tubercidin is primarily due to hepatic and renal injuries and, to a lesser extent, damage to the pancreas. Coadministration of NBMPR-P at 25 mg/kg per day completely protects the mice (100% survival) from this lethal dose regimen of tubercidin[1].

Protocol

Cell Research:

[1]

- Collapse
  • Cell lines: Human bone marrow cells
  • Concentrations: 10 nM
  • Incubation Time: 14 days
  • Method:

    Human bone marrow cells were obtained from healthy volunteers. In the protection studies, cells are exposed to 10 nM of tubercidin in the presence or absence of various doses of NBMPR-P. Cells are continuously exposed to drugs for 14 days in a humidified atmosphere of 5% C02-95% air at 37°C. Colonies of CFU-GM (250 cells) and BFU-E (>30 hemoglobinized cells) are counted with an inverted microscope.


    (Only for Reference)
Animal Research:

[1]

- Collapse
  • Animal Models: CD1 mice
  • Dosages: 5 mg/kg
  • Administration: i.p.
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 53 mg/mL (199.06 mM)
Water Insoluble
Ethanol Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 266.25
Formula

C11H14N4O4

CAS No. 69-33-0
Storage powder
in solvent
Synonyms 7-deaza-adenosine
Smiles C1=CN(C2=NC=NC(=C21)N)C3C(C(C(O3)CO)O)O

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and SDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Tubercidin | Tubercidin supplier | purchase Tubercidin | Tubercidin cost | Tubercidin manufacturer | order Tubercidin | Tubercidin distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID